Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial
about
Probiotics for prevention of necrotizing enterocolitis in preterm infantsProbiotics for prevention of necrotizing enterocolitis in preterm infantsProbiotics for prevention of necrotizing enterocolitis in preterm infantsProbiotics and Time to Achieve Full Enteral Feeding in Human Milk-Fed and Formula-Fed Preterm Infants: Systematic Review and Meta-AnalysisProbiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled TrialsComposition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gapsThe human neonatal gut microbiome: a brief reviewProbiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysisProbiotics and necrotizing enterocolitis: finding the missing pieces of the probiotic puzzle.Lactobacillus acidophilus/Bifidobacterium infantis probiotics are associated with increased growth of VLBWI among those exposed to antibiotics.Evidence-based guidelines for use of probiotics in preterm neonates.Mining the microbiota of the neonatal gastrointestinal tract for conjugated linoleic acid-producing bifidobacteria.Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primersEffects of four Bifidobacteria on obesity in high-fat diet induced rats.Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome.Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants.Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study.Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart diseaseAssociation between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review.Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trialProbiotics for preterm infants?Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria.A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart diseaseBenefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort StudyProbiotics and prebiotics: role in prevention of nosocomial sepsis in preterm infants.Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?Probiotic administration in congenital heart disease: a pilot study.A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis.A comparison of two probiotic strains of bifidobacteria in premature infantsRecent developments in necrotizing enterocolitis.Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review.Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study.Probiotics and clinical effects: is the number what counts?A systematic review of the safety of probiotics.Early optimal nutrition improves neurodevelopmental outcomes for very preterm infants.A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonatesProbiotics in neonatal intensive care - back to the future.Probiotics and necrotizing enterocolitis.Probiotic supplementation for preventing invasive fungal infections in preterm neonates--a systematic review and meta-analysis.
P2860
Q24197461-A415838E-E19E-4F58-A56A-33CE31E18D30Q24235681-7012BE9E-0031-48C5-AC47-DE9BC6470136Q24242683-EBBD6FC2-13FA-48A6-A0A1-A2E8F913134FQ26739951-177FC8F6-4A15-4666-B66F-9E084372C135Q26764805-08CEA49A-24FC-4531-8AA6-B263433EF47EQ27006760-FA7BBE0E-CF5E-4AF9-A67F-68E150F30BC8Q28080685-F04DB42C-5E64-485C-A6F9-3126D1D5B28AQ28081613-2212B1F2-0D61-46FD-AE5A-FE739050F60DQ33355303-3DC3D62C-5AF7-49D0-8331-D8EDFB0CBF51Q33912012-1E1E5D88-72A2-4D41-A204-6445375DCD22Q33977758-1B6B9E00-931E-47A4-A265-7C0A31DC20C3Q33980432-2378430E-3B49-4A54-B471-DC1F33CAA792Q33985774-910DFD95-2B93-44DB-B094-FC9C0C0406AAQ33998629-F2168BCC-2DCE-4FA4-8F14-412E3D5E25EBQ34470700-5615A830-F654-4152-A873-9B8F56368023Q34602603-8CFDED3A-4268-4EFB-B9E2-FF750F3814BDQ34623410-8A4BB814-8BC7-478C-B956-3C329952328AQ34664102-5B672F4F-173D-40E7-890A-80235CC6CD65Q35039235-0C71A3A2-4D6A-4736-B3B9-FAA622931AF6Q35110845-E7EDF1A8-4585-4E70-A26F-9BDC32407B22Q35205685-72372EB2-55EA-4A2C-8EA1-F6B37F1C2480Q35539776-60E401EA-C4F9-4251-9958-8B4E497F32E2Q35584456-339A4D59-A18A-443E-AD9F-5C5C27DE387CQ35949040-2A59A698-6553-4A35-AD18-430007B86F0EQ36569565-C854926D-A6DC-48E0-A7D7-463B1FA005E2Q36619112-2040E722-CA5D-4E04-955B-3BA1EBB00CEAQ37135148-9DDC393B-F837-425E-983B-A0DE6E3198DAQ37345483-8C0558F7-0559-4DFD-B94B-3AD43523EDFBQ37347035-4CDD6C4F-6A61-45B7-A926-EAEC93881946Q37347505-18FC661D-8CD4-4EB7-905A-639EDE67130AQ37975157-9EECB01E-9D6F-47A1-9410-0D9D33550469Q38038697-24ED0937-71FD-4C99-A092-A00801594032Q38122425-002567D7-4545-46C2-9047-E95837F0CD17Q38125810-5B093200-33EA-44A8-B35D-9CD246ECCB75Q38176954-1C00DD80-E763-4E8F-BF21-E5C30C3FC32EQ38221038-4B62DF7B-AE11-47DB-854F-E7AAFF6CADFDQ38237458-36F53117-3FAB-4A2C-B9A9-BEFDA8655F84Q38520257-6E8C29B4-7C2D-40AE-AC4F-4548ACA0ADCFQ38590665-621B1655-8095-4560-A96B-70D4C8D6D77FQ38607616-8CC90111-F85E-480A-9A36-28B5F00C5AE6
P2860
Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Early administration of Bifido ...... s: randomised controlled trial
@ast
Early administration of Bifido ...... s: randomised controlled trial
@en
type
label
Early administration of Bifido ...... s: randomised controlled trial
@ast
Early administration of Bifido ...... s: randomised controlled trial
@en
prefLabel
Early administration of Bifido ...... s: randomised controlled trial
@ast
Early administration of Bifido ...... s: randomised controlled trial
@en
P2093
P2860
P356
P1476
Early administration of Bifido ...... s: randomised controlled trial
@en
P2093
P2860
P304
P356
10.1136/FN.76.2.F101
P577
1997-03-01T00:00:00Z